Paper21099112
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
Gardenghi S and 18 others. J Clin Invest, 2010. Cited by 194 papers, by iCite.
Cite this record
ConductScience Library. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. Papers, record 21099112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21099112
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimicrobial Cationic Peptides | Major topic |
| Iron Overload | Major topic |
| beta-Thalassemia | Major topic |
| Animals | |
| Base Sequence | |
| DNA Primers | |
| Disease Models, Animal | |
| Erythropoiesis | |
| Gene Expression | |
| Hepcidins | |
| Humans | |
| Iron | |
| Iron, Dietary | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Mutant Strains | |
| Mice, Transgenic | |
| Recombinant Proteins |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK090554 | NIDDK NIH HHS | United States | R01DK090554 | PubMed and NIH | NIH RePORTER |
| R01 DK082717 | NIDDK NIH HHS | United States | R01DK082717 | PubMed and NIH | NIH RePORTER |
| 1R01DK090554-01 | NIDDK NIH HHS | United States | R01DK090554 | PubMed and NIH | NIH RePORTER |
| KO1DK065635 | NIDDK NIH HHS | United States | K01DK065635 | PubMed and NIH | NIH RePORTER |
| K01 DK065635 | NIDDK NIH HHS | United States | K01DK065635 | PubMed and NIH | NIH RePORTER |
| R01 DK055463 | NIDDK NIH HHS | United States | R01DK055463 | PubMed and NIH | NIH RePORTER |
| R01DK55463 | NIDDK NIH HHS | United States | R01DK055463 | PubMed and NIH | NIH RePORTER |
| 5R01DK082717 | NIDDK NIH HHS | United States | R01DK082717 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 21099105 | A tincture of hepcidin cures all: the potential for hepcidin therapeutics. | https://conductscience.org/library/papers/21099105 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7568113 | Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7568113 | PubMed |
| 2 | 19318943 | Ineffective erythropoiesis and thalassemias. | Curr Opin Hematol | 2009 | https://conductscience.org/library/papers/19318943 | PubMed |
| 3 | 19805084 | Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19805084 | PubMed |
| 4 | 1690033 | The role of membrane skeletal-associated alpha-globin in the pathophysiology of beta-thalassemia. | Blood | 1990 | https://conductscience.org/library/papers/1690033 | PubMed |
| 5 | 17018382 | Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. | Haematologica | 2006 | https://conductscience.org/library/papers/17018382 | PubMed |
| 6 | 11034317 | LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. | FEBS Lett | 2000 | https://conductscience.org/library/papers/11034317 | PubMed |
| 7 | 16339650 | Survival and complications in thalassemia. | Ann N Y Acad Sci | 2005 | https://conductscience.org/library/papers/16339650 | PubMed |
| 8 | 12480689 | A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. | Blood | 2003 | https://conductscience.org/library/papers/12480689 | PubMed |
| 9 | 465354 | Mechanism of desferrioxamine-induced iron excretion in thalassaemia. | Br J Haematol | 1979 | https://conductscience.org/library/papers/465354 | PubMed |
| 10 | 17110456 | Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. | Blood | 2007 | https://conductscience.org/library/papers/17110456 | PubMed |
| 11 | 8524813 | A mouse model for beta 0-thalassemia. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/8524813 | PubMed |
| 12 | 15545996 | Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15545996 | PubMed |
| 13 | 4796508 | Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia. | Z Kinderheilkd | 1973 | https://conductscience.org/library/papers/4796508 | PubMed |
| 14 | 15684421 | Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15684421 | PubMed |
| 15 | 18480424 | Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. | Blood | 2008 | https://conductscience.org/library/papers/18480424 | PubMed |
| 16 | 16755567 | mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. | Am J Hematol | 2006 | https://conductscience.org/library/papers/16755567 | PubMed |
| 17 | 11113131 | Hepcidin, a urinary antimicrobial peptide synthesized in the liver. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11113131 | PubMed |
| 18 | 17299088 | Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. | Blood | 2007 | https://conductscience.org/library/papers/17299088 | PubMed |
| 19 | 11113132 | A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11113132 | PubMed |
| 20 | 90918 | Iron absorption and loading in beta-thalassaemia intermedia. | Lancet | 1979 | https://conductscience.org/library/papers/90918 | PubMed |
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 194 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698910 | Contemporary Management of Thalassemia: A Perspective on Current Standards and the Emergence of FDA-Approved Oral Therapy. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42698910 | PubMed |
| 41892286 | CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy. | Cells | 2026 | https://conductscience.org/library/papers/41892286 | PubMed |
| 41616282 | Multiomics analysis of red blood cells reveals thalassemia severity beyond globin gene mutations. | Blood Adv | 2026 | https://conductscience.org/library/papers/41616282 | PubMed |
| 40603805 | Current Landscape of Hepcidin Therapeutics. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40603805 | PubMed |
| 40603790 | Iron-Loading Anemias. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40603790 | PubMed |
| 39987410 | Hepcidin mediates the disorder of iron homeostasis and mitochondrial function in mice under hypobaric hypoxia exposure. | Apoptosis | 2025 | https://conductscience.org/library/papers/39987410 | PubMed |
| 39979989 | Three signalling pathways for iron overload in osteoporosis: a narrative review. | J Orthop Surg Res | 2025 | https://conductscience.org/library/papers/39979989 | PubMed |
| 39396974 | Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39396974 | PubMed |
| 39250719 | In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice. | Blood Adv | 2024 | https://conductscience.org/library/papers/39250719 | PubMed |
| 38949981 | Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy. | Blood | 2024 | https://conductscience.org/library/papers/38949981 | PubMed |
| 38241484 | A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice. | Blood Adv | 2024 | https://conductscience.org/library/papers/38241484 | PubMed |
| 38223482 | Effects of Thalidomide on Erythropoiesis and Iron Homeostasis in Transfusion-Dependent β-Thalassemia. | Mediterr J Hematol Infect Dis | 2024 | https://conductscience.org/library/papers/38223482 | PubMed |
| 37146247 | Fetal factors disrupt placental and maternal iron homeostasis in murine β-thalassemia. | Blood | 2023 | https://conductscience.org/library/papers/37146247 | PubMed |
| 36995275 | Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia. | Blood Adv | 2023 | https://conductscience.org/library/papers/36995275 | PubMed |
| 36909243 | Editorial: Stress erythropoiesis. | Front Physiol | 2023 | https://conductscience.org/library/papers/36909243 | PubMed |
| 36633882 | (De)ironing out sickle cell disease. | Blood | 2023 | https://conductscience.org/library/papers/36633882 | PubMed |
| 36079046 | Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia? | J Clin Med | 2022 | https://conductscience.org/library/papers/36079046 | PubMed |
| 35720412 | Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720412 | PubMed |
| 35624729 | Role of Iron in Aging Related Diseases. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624729 | PubMed |
| 35052868 | Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. | Biomedicines | 2022 | https://conductscience.org/library/papers/35052868 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HAMP | 57817 | PubTator's text mining | https://conductscience.org/library/genes/57817 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21099112
GET https://conductscience.org/api/papers/v1/21099112/references?page=2